Literature DB >> 7803351

Retinal findings in Malawian patients with AIDS.

S Lewallen1, J Kumwenda, D Maher, A D Harries.   

Abstract

The purpose of this study was to determine the prevalence of retinal disease in a group of patients with AIDS in Malawi. Indirect ophthalmoscopy was performed on 99 patients with AIDS who were admitted consecutively to a medical ward at a central hospital. Necrotising retinitis was present in one eye of one patient examined. Non-infectious retinopathy was present in 13%. Retinitis is less common in AIDS patients from Africa compared with those from developed countries; it is believed that most patients die before acquiring it. Non-infectious retinopathy may also be less common.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Biology; Clinical Research; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Malawi; Ophthalmological Effects; Physiology; Research Methodology; Research Report; Retinal Effects; Viral Diseases

Mesh:

Year:  1994        PMID: 7803351      PMCID: PMC504929          DOI: 10.1136/bjo.78.10.757

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  The new tuberculosis.

Authors:  K De Cock
Journal:  Afr Health       Date:  1994-03

2.  Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease.

Authors:  J S Pepose; G N Holland; M S Nestor; A J Cochran; R Y Foos
Journal:  Ophthalmology       Date:  1985-04       Impact factor: 12.079

3.  Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.

Authors:  B S Peters; E J Beck; S Anderson; D Coleman; R Coker; J Main; C Migdal; J R Harris; A J Pinching
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

Review 4.  The clinical challenge of the HIV epidemic in the developing world.

Authors:  C F Gilks
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

5.  Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.

Authors:  H Whittle; A Egboga; J Todd; T Corrah; A Wilkins; E Demba; G Morgan; M Rolfe; N Berry; R Tedder
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

6.  Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome.

Authors:  T P Margolis; C Y Lowder; G N Holland; R F Spaide; A G Logan; S S Weissman; A R Irvine; R Josephberg; D M Meisler; J J O'Donnell
Journal:  Am J Ophthalmol       Date:  1991-08-15       Impact factor: 5.258

Review 7.  Tuberculosis and HIV infection in sub-Saharan Africa.

Authors:  K M De Cock; B Soro; I M Coulibaly; S B Lucas
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

8.  A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa.

Authors:  P Kestelyn; P Van de Perre; D Rouvroy; P Lepage; J Bogaerts; D Nzaramba; N Clumeck
Journal:  Am J Ophthalmol       Date:  1985-08-15       Impact factor: 5.258

9.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

10.  Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy.

Authors:  W R Freeman; A Chen; D E Henderly; A M Levine; J K Luttrull; P T Urrea; J Arthur; S Rasheed; J L Cohen; D Neuberg
Journal:  Am J Ophthalmol       Date:  1989-03-15       Impact factor: 5.258

View more
  12 in total

1.  The challenge of HIV/AIDS related eye disease.

Authors:  P Courtright
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

2.  AIDS related eye disease in Burundi, Africa.

Authors:  I Cochereau; N Mlika-Cabanne; P Godinaud; T Niyongabo; B Poste; A Ngayiragije; M C Dazza; P Aubry; B Larouzé
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

3.  Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.

Authors:  M Burke; I Yust; C Katlama; N Vardinon; N Clumeck; A J Pinching; B Ledergerber; J M Gatell; A Chiesi; S E Barton; J D Lundgren; C Pedersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

4.  Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa.

Authors:  N A V Beare; J G Kublin; D K Lewis; M J Schijffelen; R P H Peters; G Joaki; J Kumwenda; E E Zijlstra
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Ocular complications of HIV infection in sub-Sahara Africa.

Authors:  Oathokwa Nkomazana; Dintle Tshitswana
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

6.  [Tropical ophthalmology--prevention and therapy"Vision 2020--the right to sight"].

Authors:  V Klauss; U C Schaller
Journal:  Ophthalmologe       Date:  2004-06-16       Impact factor: 1.059

7.  Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa.

Authors:  Sophia Pathai; Clare Gilbert; Helen A Weiss; Matthew McNally; Stephen D Lawn
Journal:  Trop Med Int Health       Date:  2011-01-05       Impact factor: 2.622

8.  Ocular disease in patients with TB and HIV presenting with fever in Malawi.

Authors:  Nav Beare; J G Kublin; D K Lewis; M J Schijffelen; Rph Peters; G Joaki; K Kumwenda; E E Zijlstra
Journal:  Malawi Med J       Date:  2003       Impact factor: 0.875

9.  Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study.

Authors:  Sisay Bekele; Yeshigeta Gelaw; Fasil Tessema
Journal:  BMC Ophthalmol       Date:  2013-05-27       Impact factor: 2.209

10.  Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study.

Authors:  Sophia Pathai; Alaka Deshpande; Clare Gilbert; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2009-09-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.